针治疗COVID-19后失眠的有效性和安全性:系统审查和元分析协议
Yadi Li1,2, Jianlong Zhou3, Zheng Wei1
1Deyang People's Hospital, Deyang, China.
JMIR research protocols
|March 7, 2025
概括
针在治疗COVID-19后失眠 (PCI) 方面表现有前途,提供了一个安全且具有成本效益的替代方案. 本系统性审查评估了其有效性,以指导长期COVID患者的临床实践.
科学领域:
- 综合医学是一个整体的医学.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,导致了长期的COVID,包括COVID-19后失眠 (PCI).
- 传统的PCI治疗在有效性,安全性和成本上都有局限性.
- 针正在成为PCI的可行,经济有效和安全的治疗选择.
研究的目的:
- 系统地审查和元分析针治疗PCI的疗效和安全性.
- 为了确定PCI管理的最佳针模式,频率和持续时间.
- 为PCI治疗中的临床实践和决策提供基于证据的指导.
主要方法:
- 在2024年10月之前,对12个数据库 (英语和中文) 进行全面搜索.
- 包括针对PCI的针随机对照试验.
- 使用风险比率和平均差异进行数据综合;通过Cochrane手册进行质量评估;使用RevMan 5.3.3进行元分析.
主要成果:
- 该研究将提供有关针治疗PCI疗效的证据,包括反应率和失眠严重程度.
- 将对传统中医症状量表 (TCMSS) 评分和不良事件发生率进行分析.
- 将提供基于证据的关于针治疗PCI的有效性和安全性的综述.
结论:
- 本系统性审查将总结目前关于PCI针的证据.
- 调查结果将为管理PCI的临床实践和决策提供信息.
- 将确定研究缺口,以指导未来对针治疗COVID-19后情况的调查.
相关概念视频
01:27Insomnia
78
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
78
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143